Singapore, May 15 -- The Research Institute for Cancer Prevention, Screening and Early Detection (RISE), jointly led by the National Cancer Centre Singapore (NCCS) and NTU Singapore, has announced the launch of two studies; one led by NCCS to evaluate multi-cancer early detection (MCED) tests and another led by the Lee Kong Chian School of Medicine (LKCMedicine) at NTU Singapore to develop targeted screening and prevention for metabolic dysfunction-linked cancers in Singapore.

MCED tests are an emerging cancer screening technology worldwide but there is limited evidence currently to show that they improve population health outcomes. The NCCS team will conduct a clinical trial to comprehensively evaluate the use of MCED tests to identify ...